Design, synthesis and biological activity of tetrazole-bearing uric acid transporter 1 inhibitors
Wenqing Cai , Wei Liu , Yafei Xie , Jingwei Wu , Yuqiang Liu , Changying Liu , Weiren Xu , Lida Tang , Jianwu Wang , Guilong Zhao
Chemical Research in Chinese Universities ›› 2017, Vol. 33 ›› Issue (1) : 49 -60.
Design, synthesis and biological activity of tetrazole-bearing uric acid transporter 1 inhibitors
Systematic structure-activity relationship(SAR) exploration of a moderately active tetrazole-bearing lesinurad-based hit 1f led to the discovery of a potent uric acid transporter 1(URAT1) inhibitor 1i, which possessed a novel molecular skeleton and was 11-fold more potent than the parent lesinurad against human URAT1 in-vitro (IC50=0.66 μmol/L for 1i vs. 7.18 μmol/L for lesinurad).
URAT1 inhibitor / Structure-activity relationship / Drug discovery / Lesinurad / Tetrazole / Bioisostere
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
Zhang X., Wu J., Liu W., Liu Y., Xie Y., Shang Q., Zhou Z., Xu W., Tang L., Wang J., Zhao G., Med. Chem., 10.2174/1573406412666160915163002 |
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
/
| 〈 |
|
〉 |